A detailed history of Bard Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bard Financial Services, Inc. holds 50,640 shares of BMY stock, worth $2.16 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
50,640
Previous 57,265 11.57%
Holding current value
$2.16 Million
Previous $3.11 Million 32.27%
% of portfolio
0.22%
Previous 0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$40.25 - $52.99 $266,656 - $351,058
-6,625 Reduced 11.57%
50,640 $2.1 Million
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $239,899 - $272,000
-5,000 Reduced 8.03%
57,265 $3.11 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $148,833 - $177,599
-3,070 Reduced 4.7%
62,265 $3.19 Million
Q3 2023

Oct 16, 2023

BUY
$57.89 - $64.73 $20,261 - $22,655
350 Added 0.54%
65,335 $3.79 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $4,928 - $5,589
-75 Reduced 0.12%
64,985 $4.5 Million
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $56,496 - $66,899
-825 Reduced 1.25%
65,060 $4.68 Million
Q3 2022

Oct 26, 2022

SELL
$0.13 - $76.84 $91 - $53,788
-700 Reduced 1.05%
65,885 $4.68 Million
Q2 2022

Jul 06, 2022

SELL
$72.62 - $79.98 $36,310 - $39,990
-500 Reduced 0.75%
66,585 $5.13 Million
Q1 2022

Apr 13, 2022

BUY
$61.48 - $73.72 $32,584 - $39,071
530 Added 0.8%
67,085 $4.9 Million
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $8,044 - $9,378
-150 Reduced 0.22%
66,555 $4.15 Million
Q3 2021

Oct 15, 2021

BUY
$59.17 - $69.31 $21,005 - $24,605
355 Added 0.54%
66,705 $3.95 Million
Q2 2021

Jul 13, 2021

SELL
$61.91 - $67.42 $15,477 - $16,855
-250 Reduced 0.38%
66,350 $4.43 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $256,645 - $288,650
4,325 Added 6.95%
66,600 $4.2 Million
Q4 2020

Mar 26, 2021

BUY
$57.74 - $65.43 $3.6 Million - $4.07 Million
62,275 New
62,275 $3.86 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $90.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.